89 related articles for article (PubMed ID: 16216595)
1. Antibodies against oxidized LDL and cardiolipin and mortality in patients with coronary heart disease.
Erkkilä AT; Närvänen O; Lehto S; Uusitupa MI; Ylä-Herttuala S
Atherosclerosis; 2005 Nov; 183(1):157-62. PubMed ID: 16216595
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease.
Erkkilä AT; Närvänen O; Lehto S; Uusitupa MI; Ylä-Herttuala S
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):204-9. PubMed ID: 10634819
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction.
Wu R; Nityanand S; Berglund L; Lithell H; Holm G; Lefvert AK
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3159-63. PubMed ID: 9409306
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
[TBL] [Abstract][Full Text] [Related]
5. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population.
Meisinger C; Baumert J; Khuseyinova N; Loewel H; Koenig W
Circulation; 2005 Aug; 112(5):651-7. PubMed ID: 16043640
[TBL] [Abstract][Full Text] [Related]
6. Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.
McGovern PG; Pankow JS; Shahar E; Doliszny KM; Folsom AR; Blackburn H; Luepker RV
N Engl J Med; 1996 Apr; 334(14):884-90. PubMed ID: 8596571
[TBL] [Abstract][Full Text] [Related]
7. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
[TBL] [Abstract][Full Text] [Related]
8. Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty.
George J; Harats D; Bakshi E; Adler Y; Levy Y; Gilburd B; Shoenfeld Y
Immunol Lett; 1999 Jun; 68(2-3):263-6. PubMed ID: 10424430
[TBL] [Abstract][Full Text] [Related]
9. High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men--a nested case-control study.
Palosuo T; Virtamo J; Haukka J; Taylor PR; Aho K; Puurunen M; Vaarala O
Thromb Haemost; 1997 Oct; 78(4):1178-82. PubMed ID: 9364981
[TBL] [Abstract][Full Text] [Related]
10. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men.
Vaarala O; Mänttäri M; Manninen V; Tenkanen L; Puurunen M; Aho K; Palosuo T
Circulation; 1995 Jan; 91(1):23-7. PubMed ID: 7805207
[TBL] [Abstract][Full Text] [Related]
11. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
[TBL] [Abstract][Full Text] [Related]
12. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus.
Koskenmies S; Vaarala O; Widen E; Kere J; Palosuo T; Julkunen H
Scand J Rheumatol; 2004; 33(4):246-52. PubMed ID: 15370721
[TBL] [Abstract][Full Text] [Related]
13. Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Apr; 117(4):511-5. PubMed ID: 15109440
[TBL] [Abstract][Full Text] [Related]
14. Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies.
Sherer Y; Tenenbaum A; Praprotnik S; Shemesh J; Blank M; Fisman EZ; Harats D; George J; Levy Y; Peter JB; Motro M; Shoenfeld Y
Cardiology; 2001; 95(1):20-4. PubMed ID: 11385187
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against oxidized LDL are associated with severe chest pain attacks in patients with coronary heart disease.
Luoma JS; Kareinen A; Närvänen O; Viitanen L; Laakso M; Ylä-Herttuala S
Free Radic Biol Med; 2005 Dec; 39(12):1660-5. PubMed ID: 16298691
[TBL] [Abstract][Full Text] [Related]
16. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
Maradit-Kremers H; Crowson CS; Nicola PJ; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
Arthritis Rheum; 2005 Feb; 52(2):402-11. PubMed ID: 15693010
[TBL] [Abstract][Full Text] [Related]
17. Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.
Wong TY; Tikellis G; Sun C; Klein R; Couper DJ; Sharrett AR
Ophthalmology; 2007 Jan; 114(1):86-91. PubMed ID: 17198851
[TBL] [Abstract][Full Text] [Related]
18. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL
Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060
[TBL] [Abstract][Full Text] [Related]
19. Minimally modified electronegative LDL and its autoantibodies in acute and chronic coronary syndromes.
Oliveira JA; Sevanian A; Rodrigues RJ; Apolinário E; Abdalla DS
Clin Biochem; 2006 Jul; 39(7):708-14. PubMed ID: 16782081
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to oxidized LDL and cardiovascular risk: the Framingham Offspring Study.
Wilson PW; Ben-Yehuda O; McNamara J; Massaro J; Witztum J; Reaven PD
Atherosclerosis; 2006 Dec; 189(2):364-8. PubMed ID: 16476434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
